Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6422944rdf:typepubmed:Citationlld:pubmed
pubmed-article:6422944lifeskim:mentionsumls-concept:C0003693lld:lifeskim
pubmed-article:6422944lifeskim:mentionsumls-concept:C0033551lld:lifeskim
pubmed-article:6422944lifeskim:mentionsumls-concept:C1707919lld:lifeskim
pubmed-article:6422944pubmed:issue2lld:pubmed
pubmed-article:6422944pubmed:dateCreated1984-4-4lld:pubmed
pubmed-article:6422944pubmed:languageenglld:pubmed
pubmed-article:6422944pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6422944pubmed:citationSubsetIMlld:pubmed
pubmed-article:6422944pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6422944pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6422944pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6422944pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6422944pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6422944pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6422944pubmed:statusMEDLINElld:pubmed
pubmed-article:6422944pubmed:monthJanlld:pubmed
pubmed-article:6422944pubmed:issn0006-2952lld:pubmed
pubmed-article:6422944pubmed:authorpubmed-author:TatesonJ EJElld:pubmed
pubmed-article:6422944pubmed:authorpubmed-author:IslipP JPJlld:pubmed
pubmed-article:6422944pubmed:authorpubmed-author:CoppF CFClld:pubmed
pubmed-article:6422944pubmed:issnTypePrintlld:pubmed
pubmed-article:6422944pubmed:day15lld:pubmed
pubmed-article:6422944pubmed:volume33lld:pubmed
pubmed-article:6422944pubmed:ownerNLMlld:pubmed
pubmed-article:6422944pubmed:authorsCompleteYlld:pubmed
pubmed-article:6422944pubmed:pagination339-40lld:pubmed
pubmed-article:6422944pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:meshHeadingpubmed-meshheading:6422944-...lld:pubmed
pubmed-article:6422944pubmed:year1984lld:pubmed
pubmed-article:6422944pubmed:articleTitle3-N-substituted-amino-1-[3-(trifluoromethyl)phenyl]-2-pyrazolines have enhanced activity against arachidonate 5-lipoxygenase and cyclooxygenase.lld:pubmed
pubmed-article:6422944pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6422944pubmed:publicationTypeIn Vitrolld:pubmed